The Effects of a Crosslinked, Modified Hyaluronic Acid (xCMHA-S) Gel on Equine Tendon Healing.
Authors: Jann Henry W, Hart James C A, Stein Larry E, Ritchey Jerry, Blaik Margaret, Payton Mark, Fackelman Gustave E, Rezabek Grant B, Mann Brenda K
Journal: Veterinary surgery : VS
Summary
# Editorial Summary: Crosslinked Modified Hyaluronic Acid Gel in Equine Tendon Healing Researchers investigated whether intraoperative application of a crosslinked, modified hyaluronic acid gel (xCMHA-S) could enhance healing in surgically induced superficial digital flexor tendon lesions, using a controlled bilateral forelimb model in five adult horses with ultrasound monitoring over 84 days and subsequent histological analysis. Treatment with xCMHA-S resulted in complete lesion closure on ultrasound (0% remaining) versus persistent 30% lesion size in untreated controls, alongside significantly superior histological healing scores (13.6 versus 17.7 on cumulative scoring), suggesting accelerated tissue maturation in the treated group. Interestingly, the mechanism did not involve differences in collagen fibre characteristics, haemorrhage, or fibroblast morphology; instead, the treated tendons demonstrated reduced inflammatory infiltration and more controlled neovascularisation compared to controls, which exhibited excessive cell density and chaotic vascularisation typical of disorganised healing. For practitioners managing tendon injuries, these findings suggest that xCMHA-S gel application at the time of acute injury or surgical debridement may modulate the inflammatory phase and promote more orderly tissue remodelling, though the clinical translation and timing of application in naturally occurring injuries warrants further investigation.
Read the full abstract on PubMed
Practical Takeaways
- •xCMHA-S gel application at the time of acute tendon injury may accelerate healing and reduce lesion size over 12 weeks
- •This scaffold material shows promise for managing superficial digital flexor tendon injuries, though results are from small experimental study requiring clinical validation
- •The gel appears to modulate the inflammatory response and tissue remodeling rather than changing fundamental collagen architecture
Key Findings
- •xCMHA-S gel-treated tendons showed 0% lesion size at 84 days versus 30% in untreated controls on ultrasound
- •Treated tendons had significantly lower histologic scores (13.6 vs 17.7), indicating more advanced healing
- •Control tendons showed increased neovascularization, inflammation intensity, and tendon cell density compared to treated tendons
- •No differences observed in collagen fiber linearity, diameter, distribution, fibroblast shape, or intralesional hemorrhage between groups